CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Curia Global, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Curia Global, Inc.
26 Corporate Circle
Phone: 518-512-2000p:518-512-2000 Albany, NY  12203  United States

This company was Merged or Acquired on 8/31/2017.
This company ceased filing statements with the SEC on 8/31/2017.
Acquired by GTCR, LLC and The Carlyle Group LP.
This company is no longer actively traded on any major stock exchange.

Business Summary
Curia Global, Inc., formerly known as Albany Molecular Research, Inc. (AMRI), is a global contract research, development and manufacturing organization (CDMO), offering products and services across the drug development spectrum. The Company's biologics and small molecule offering spans discovery through commercialization, with integrated regulatory and analytical capabilities. It provides scientific expertise and technologies to support the chemical development and cGMP manufacture of complex APIs, including generics, potent and cytotoxic compounds, sterile APIs, steroids and controlled substances. The Company's portfolio includes more than 240 commercial APIs, including generics, along with products and services from more than 12 GMP manufacturing facilities in the US, Spain, Italy, France, Germany and India. The Company is headquartered in Albany, New York.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
---YesYes--

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
--YesYes--Yes

Subsidiaries
Business Name Address City State/Province Country
ALBANY MOLECULAR RESEARCH, INC. (OLD)
ALBANY MOLECULAR RESEARCH LIMITED FIRST FLOOR TEMPLEBACK 10 TEMPLE BACK UK
CURIA HOLDINGS (UK) LIMITED FIRST FLOOR TEMPLEBACK 10 TEMPLE BACK UK
13 additional Subsidiary records available in full report.

Business Names
Business Name
Albany Molecular Luxembourg S.à r.l.
Albany Molecular Research (Glasgow) Limited
Albany Molecular Research (UK) Limited
60 additional Business Names available in full report.

General Information
Stock Exchange: NASD
Federal Tax Id: 141742717


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, March 18, 2024